Company news

Arovella Therapeutics Limited news in 2024

Arovella Therapeutics Limited's news releases, calls and decks from 2024, newest first.

View company

Arovella receives R&D tax rebate of $3.0 million

October 25, 2024

Positive pre-IND feedback from FDA for ALA-101

August 6, 2024

Zolpimist Update

June 12, 2024

Arovella completes manufacturing scale-up

June 4, 2024

Arovella Completes $12.5M Placement - Funded to Phase 1 Data

March 25, 2024

Pause in Trading

March 21, 2024

Appendix 4D and Half Year Report

February 28, 2024

Arovella licenses novel CAR-iNKT cell armouring technology

January 29, 2024

Decks in 2024